Quick BloodPressure is a manual health-tracking tool for blood pressure and heart rate, available on iOS.
Product velocity
Unknown
Daily rank 🇺🇸
—
Health & Fitness
Sentiment
3.1
287 reviews
Nemesis
OMRON connect US/CAN/EMEA
The App DNA
What makes this app unique?
Users hire the app to maintain a personal health log without cloud-sync requirements, though the current ad-heavy experience prevents the app from fulfilling this job.
For Individuals seeking a manual, privacy-focused tool for tracking blood pressure and heart rate trends alongside basic dietary guidance.
Key features
Manual entry of systolic and diastolic readings with historical timeline visualization
Manual logging of heart rate data to track daily trends
Collection of practical recipes for balanced lifestyle support
Records stored exclusively on the device without cloud synchronization
How much does it cost?
The app operates on a free model with no visible IAP or subscription gates in the current metadata.
Velocity
Steady developmentShow more...
Who built it?
Far Vision
4 apps tracked · Health & Fitness
User Sentiment
What do users think recently?
Fresh user feedback skews upset.
How are ratings & reviews evolving?
What users say, by theme
- Aggressive advertising patterns prevent users from accessing core functionality or health readings
8 of 8 recent reviews analyzed · limited sample · Upset overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Quick BloodPressure
How's the Health & Fitness market?
The app maintains a presence in the Health & Fitness category across multiple international markets, though it frequently fluctuates in the #50–#100 range. This volatility, combined with a 3.1-star rating, indicates that the current ad-delivery mechanism is failing to convert discovery into a stable user base.
Read the market outlookThe rivals identified
By Omron Healthcare, Inc.
This is the dominant market leader for blood pressure tracking, leveraging direct hardware integration that creates a high barrier to entry.
- Direct Bluetooth synchronization with medical-grade hardware removes manual entry friction for users
- Clinical-grade data validation provides trust that generic manual trackers cannot replicate
- Deep integration with health ecosystems like Apple Health and Google Fit for automated data sharing
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Quick BloodPressure
Where is it heading?
The health tracking market is consolidating around apps that provide either seamless hardware integration or AI-driven insights. Quick BloodPressure is currently exposed, as its reliance on ad-delivery creates a negative feedback loop that will likely lead to platform policy enforcement actions.
- Aggressive ad-interruption prevents core feature access, which drives high churn and negative sentiment across the user base.
- The latest update failed to address core usability issues, signaling that the app is currently in a maintenance-mode decline.
The SWOT
- Local-only data storage provides privacy-focused utility without cloud-sync friction
- Pivot to subscription model to remove ad-friction
Next best moves
Audit ad-placement logic because user complaints flag ad-frequency as the top churn driver → improve retention
+ 1 more prioritized moveThe counter-intuitive read
The app's privacy-focused local storage is a liability rather than a strength…
Read the full takeFeature gaps
Direct hardware synchronization (available in OMRON connect but absent here) +1
Since the last report: The product has transitioned from a standard health-tracking tool to a failing, ad-heavy application, resulting in significant user churn and negative sentiment.
Bottom line
The app is failing to provide basic utility because aggressive ad-delivery blocks core features, so the PM should pivot to a subscription model to remove ad-friction and stabilize the user base.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated